Gene Sequencing tests in Dubai & UAE

Compare available Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

143

Listed price range

2,600.00–3,200.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Gene Sequencing test prices

Showing 1–15 of 143 matching tests.

Gene Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5861 ABCA3 Gene Surfactant Metabolism Dysfunction Type 3 Genetic Test This test evaluates the ABCA3 gene for pathogenic variants associated with Surfactant Metabolism Dysfunction Type 3.	Peripheral whole blood (2–5 mL in EDTA tube)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ABCA3 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["Mandatory pre-test genetic counseling session", "Three-generation pedigree chart construction"] Indications ["Suspected Surfactant Metabolism Dysfunction Type 3", "Neonatal respiratory distress", "Carrier screening", "Prenatal planning"] Measurement technique Confirm with laboratory Codes LOINC: 94251-2 ICD-10: J84.81 Clinical summary This test evaluates the ABCA3 gene for pathogenic variants associated with Surfactant Metabolism Dysfunction Type 3.
TEST-4862 ABCB1 Gene Inflammatory Bowel Disease Type 13 Genetic Test This test evaluates the ABCB1 gene for pathogenic variants associated with increased susceptibility to Inflammatory Bowel Disease type 13.	Whole Blood (venous)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ABCB1 gene", "P-glycoprotein function related to IBD risk"] Parameters [] Preparation ["No specific fasting required.", "Continue normal diet and medications unless advised otherwise by your doctor."] Indications ["Assessment of genetic susceptibility to IBD type 13", "Personalized risk stratification for Crohn's disease and ulcerative colitis"] Measurement technique Confirm with laboratory Codes LOINC: 21646-6 ICD-10: Z15.09 Clinical summary This test evaluates the ABCB1 gene for pathogenic variants associated with increased susceptibility to Inflammatory Bowel Disease type 13.
TEST-6058 ACADS Gene (Acyl-CoA Short-Chain Dehydrogenase Deficiency) Genetic Test This diagnostic test evaluates the ACADS gene for mutations associated with short-chain acyl-CoA dehydrogenase deficiency (SCADD).	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ACADS gene mutations", "Single nucleotide variants", "Indels", "Copy number changes"] Parameters [{"name": "Analytical Sensitivity", "reference_range": ">99.9% for single nucleotide variants, indels, and copy number changes"}] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Suspected SCADD based on clinical symptoms", "Family history of SCADD", "Metabolic crisis", "Guidance for dietary management", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 81305-9 ICD-10: E71.31 Clinical summary This diagnostic test evaluates the ACADS gene for mutations associated with short-chain acyl-CoA dehydrogenase deficiency (SCADD).
TEST-6125 ACSF3 Gene Test for Combined Malonic and Methylmalonic Aciduria (NGS) This test identifies pathogenic variants in the ACSF3 gene associated with Combined Malonic and Methylmalonic Aciduria.	Peripheral whole blood (or tissue biopsy)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ACSF3 gene pathogenic variants", "Combined Malonic and Methylmalonic Aciduria genetic predisposition"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications or supplements"] Indications ["Suspected Combined Malonic and Methylmalonic Aciduria", "Family history of the disorder", "Carrier screening", "Peace-of-mind testing"] Measurement technique Confirm with laboratory Codes LOINC: 101872-5 ICD-10: E71.120, E71.1, Z13.79 Clinical summary This test identifies pathogenic variants in the ACSF3 gene associated with Combined Malonic and Methylmalonic Aciduria.
TEST-4166 ACTA2 Gene Multisystemic Smooth Muscle Dysfunction Syndrome Genetic Test This genetic test analyzes the ACTA2 gene for mutations associated with Multisystemic Smooth Muscle Dysfunction Syndrome (MSMDS). It identifies pathogenic variants linked to condit...	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ACTA2 gene", "Missense, nonsense, splice-site, and small insertion/deletion mutations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions"] Indications ["Clinical features suggestive of MSMDS", "Family history of ACTA2-related disease", "Unexplained thoracic aortic aneurysm/stroke in young adults"] Measurement technique Confirm with laboratory Codes LOINC: 21678-0 ICD-10: Q87.89 Clinical summary This genetic test analyzes the ACTA2 gene for mutations associated with Multisystemic Smooth Muscle Dysfunction Syndrome (MSMDS). It identifies pathogenic variants linked to conditions like thoracic aortic aneurysm, moyamoya disease, and congenital mydriasis.
TEST-4604 ADAM10 Gene Sequencing for Reticulate Acropigmentation of Kitamura (RAK) Test This test identifies pathogenic variants in the ADAM10 gene associated with Reticulate Acropigmentation of Kitamura (RAK).	Peripheral whole blood	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ADAM10 gene"] Parameters [] Preparation [] Indications ["Clinical features consistent with reticulate acropigmentation of Kitamura", "At-risk family members of a confirmed case"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: L81.8 Clinical summary This test identifies pathogenic variants in the ADAM10 gene associated with Reticulate Acropigmentation of Kitamura (RAK).
TEST-6222 ADK Gene Hypermethioninemia due to Adenosine Kinase Deficiency Test This genetic test identifies pathogenic variants in the adenosine kinase (ADK) gene, confirming a diagnosis of hypermethioninemia due to adenosine kinase deficiency.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ADK gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Suspected hypermethioninemia due to adenosine kinase deficiency", "Confirmation of biochemical findings"] Measurement technique Confirm with laboratory Codes LOINC: 81315-5 ICD-10: E72.11 Clinical summary This genetic test identifies pathogenic variants in the adenosine kinase (ADK) gene, confirming a diagnosis of hypermethioninemia due to adenosine kinase deficiency.
TEST-6266 AIFM1 Gene Combined Oxidative Phosphorylation Deficiency Type 6 Genetic Test This genetic test identifies mutations in the AIFM1 gene associated with combined oxidative phosphorylation deficiency type 6.	Whole Blood (Peripheral)	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AIFM1 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["Mandatory genetic counseling session required before testing", "No specific fasting or medication adjustments needed"] Indications ["Suspected combined oxidative phosphorylation deficiency type 6", "Positive family history of mitochondrial disease", "Clinical presentation consistent with AIFM1-related disorder"] Measurement technique Confirm with laboratory Codes LOINC: 92762-7 ICD-10: E88.4 Clinical summary This genetic test identifies mutations in the AIFM1 gene associated with combined oxidative phosphorylation deficiency type 6.
TEST-4585 AK2 Gene Reticular Dysgenesis Genetic Test This genetic test identifies pathogenic variants in the AK2 gene, confirming a diagnosis of reticular dysgenesis.	Whole Blood (EDTA) or DNA FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AK2 gene coding region", "AK2 gene splice-site junctions"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session", "Obtain informed consent"] Indications ["Suspected severe combined immunodeficiency (SCID)", "Family history of reticular dysgenesis", "Evaluation for hematopoietic stem cell transplantation"] Measurement technique Confirm with laboratory Codes LOINC: 101371-1 ICD-10: D81.0 Clinical summary This genetic test identifies pathogenic variants in the AK2 gene, confirming a diagnosis of reticular dysgenesis.
TEST-6110 ALPL Gene Hypophosphatasia (Adult) Genetic Test This genetic test identifies mutations within the ALPL gene, which are responsible for causing adult hypophosphatasia.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ALPL gene mutations", "Deletions/Duplications in ALPL gene"] Parameters [] Preparation ["No fasting required"] Indications ["Suspected adult hypophosphatasia", "Low alkaline phosphatase levels with clinical symptoms", "Family history of hypophosphatasia"] Measurement technique Confirm with laboratory Codes LOINC: 81239-4 ICD-10: E83.30, Z15.09 Clinical summary This genetic test identifies mutations within the ALPL gene, which are responsible for causing adult hypophosphatasia.
TEST-3425 AMH Gene Persistent Müllerian Duct Syndrome Type 1 Genetic Test This test detects pathogenic variants in the AMH gene associated with Persistent Müllerian Duct Syndrome Type 1.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AMH gene", "Presence of mutations causing PMDS Type 1"] Parameters [] Preparation ["Do not alter or discontinue prescribed medications without consulting your treating physician."] Indications ["Suspected Persistent Müllerian Duct Syndrome Type 1", "Individuals with ambiguous genitalia or related clinical findings", "Family history of PMDS"] Measurement technique Confirm with laboratory Codes LOINC: 81653-4 ICD-10: Q55.8 Clinical summary This test detects pathogenic variants in the AMH gene associated with Persistent Müllerian Duct Syndrome Type 1.
TEST-5058 ANO5 Gene Gnathodiaphyseal Dysplasia Genetic Test This test analyzes the ANO5 gene for mutations associated with gnathodiaphyseal dysplasia (GDD). It identifies variants like single-nucleotide changes, insertions/deletions, and co...	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ANO5 gene variants", "Single-nucleotide variants", "Insertions/deletions", "Copy-number variations"] Parameters [] Preparation ["Detailed clinical history focusing on jaw, dental, or long-bone symptoms is required.", "Mandatory genetic counselling session to construct a pedigree chart.", "No dietary or drug restrictions are necessary; continue all prescribed medications unless advised otherwise."] Indications ["Individuals with compatible clinical features", "Family history of GDD", "Inconclusive radiographic findings"] Measurement technique Confirm with laboratory Codes LOINC: 82293-6 ICD-10: M85.8, Z13.89 Clinical summary This test analyzes the ANO5 gene for mutations associated with gnathodiaphyseal dysplasia (GDD). It identifies variants like single-nucleotide changes, insertions/deletions, and copy-number variations.
TEST-3704 APOE Gene Lipoprotein Glomerulopathy Genetic Test This genetic test identifies pathogenic variants in the APOE gene associated with lipoprotein glomerulopathy.	Whole Blood (EDTA), FTA Card, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["APOE gene variants", "Pathogenic mutations"] Parameters [] Preparation ["Do not discontinue prescribed lipid-lowering, anticoagulant, or immunosuppressive medication prior to testing without explicit nephrologist approval."] Indications ["Biopsy-confirmed lipid thrombi in glomeruli", "Unexplained nephrotic syndrome with elevated apolipoprotein E levels", "Strong family history of early-onset kidney failure"] Measurement technique Confirm with laboratory Codes LOINC: 21673-1 ICD-10: E78.8 Clinical summary This genetic test identifies pathogenic variants in the APOE gene associated with lipoprotein glomerulopathy.
TEST-3764 ATP1A3 Gene Alternating Hemiplegia of Childhood Type 2 (AHC2) Genetic Test This test evaluates the ATP1A3 gene for pathogenic variants associated with Alternating Hemiplegia of Childhood type 2 (AHC2). It uses Next-Generation Sequencing (NGS) to detect va...	Whole Blood (EDTA tube), Extracted DNA, or Dried Blood Spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP1A3 gene sequence", "Pathogenic variants (point mutations, indels, copy number changes)"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Diagnosis of Alternating Hemiplegia of Childhood type 2", "Genetic confirmation", "Family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 98995-9 ICD-10: G24.3 Clinical summary This test evaluates the ATP1A3 gene for pathogenic variants associated with Alternating Hemiplegia of Childhood type 2 (AHC2). It uses Next-Generation Sequencing (NGS) to detect various mutation types.
TEST-6251 ATP5F1A Gene Combined Oxidative Phosphorylation Deficiency Type 22 Genetic Test This test identifies pathogenic variants in the ATP5F1A gene associated with combined oxidative phosphorylation deficiency type 22 (COXPD22). It uses Next-Generation Sequencing (NG...	Whole Blood (EDTA tube), Extracted DNA, or FTA Card Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP5F1A gene variants", "Single nucleotide variants", "Small insertions and deletions", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "Avoid blood transfusion within 2 weeks prior to sample collection"] Indications ["Suspected combined oxidative phosphorylation deficiency type 22 (COXPD22)", "Early-onset metabolic disorder with neurological symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 90507-4 ICD-10: E88.49 Clinical summary This test identifies pathogenic variants in the ATP5F1A gene associated with combined oxidative phosphorylation deficiency type 22 (COXPD22). It uses Next-Generation Sequencing (NGS) to analyze the entire coding region and flanking splice sites.

Category overview

Gene Sequencing: overview

Achieving a definitive diagnosis for a complex or rare genetic disorder often requires reading the entire genetic code of specific genes to find elusive, hidden errors. As a cornerstone of our advanced Genetics services, Gene Sequencing expansively scans the targeted regions of your genome to uncover rare or novel mutations that standard tests miss. Utilizing state-of-the-art sequencing technology, this comprehensive molecular profiling delivers the critical data necessary to safely guide your healthcare provider in tailoring highly personalized medical management and targeted therapeutic interventions. Trusted for molecular excellence among premier diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and remarkably fast reporting. Find the clear, definitive answers you need—schedule your gene sequencing testing in UAE, coordinate a seamless clinical sample transfer, or consult our expert medical genetics professionals today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.